Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?

• Usha Panchapakesan ,

  * E-mail: usha.panchapakesan@sydney.edu.au

  Affiliation Department of Medicine, The University of Sydney, Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia

  ⨯
• Kate Pegg,

  Affiliation Department of Medicine, The University of Sydney, Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia

  ⨯
• Simon Gross,

  Affiliation Department of Medicine, The University of Sydney, Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia

  ⨯
• Muralikrishna Gangadharan Komala,

  Affiliation Department of Medicine, The University of Sydney, Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia

  ⨯
• Harshini Mudaliar,

  Affiliation Department of Medicine, The University of Sydney, Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia

  ⨯
• Josephine Forbes,

  Affiliation Glycation and Diabetes Research Group, Mater Medical Research Institute, South Brisbane Qld, Australia

  ⨯
• Carol Pollock,

  Affiliation Department of Medicine, The University of Sydney, Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia

  ⨯
• Amanda Mather

  Affiliation Department of Medicine, The University of Sydney, Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia

  ⨯